Nigeria expects to receive nearly eight million additional doses of COVID-19 vaccines by the end of August, including from a U.S. government donation, the head of its primary care agency said on Tuesday.
Speaking during a press briefing in Abuja, Faisal Shuaib, head of the National Primary Health Care Development Agency (NPHCDA), Nigeria had exhausted its initial supply of nearly four million shots last week and aims to resume vaccinations within weeks, when the new doses arrive.
Nigeria expects delivery of 3.924 million doses of Oxford/AstraZeneca shots from global vaccine-sharing scheme COVAX by the end of July or early August, Shuaib said, and an additional 3.93 million doses of either Pfizer/Biotech or Moderna, donated by the U.S. government via COVAX, in August.
The White House last month outlined a plan to share 55 million U.S. COVID-19 vaccine doses globally via COVAX.
Nigeria, Africa’s most populous nation, recently detected the highly contagious Delta variant, while the governor of its commercial centre, Lagos state, warned that it was on the verge of a third wave of infections; this even as citizens are been urged citizens to abide by “non-pharmaceutical” measures, such as mask wearing and social distancing, to stem the spread of the virus until fresh doses arrived.
Nigeria has recorded 14,550 of mild to moderate adverse reactions to the vaccines but no fatalities linked to the shots.